Korean Biotech Database

News in the Life Sciences Industry
Results 121 - 136 out of 136 displayed.
« 1 2 3 4 5 6 7

Qu Biologics is pleased to announce the appointment of Karn Manhas to Qu’s Board of Directors

By: GlobenewsWire - 24 Aug 2020

Qu Biologics Initiates Phase 2 Study to Assess Activation of Anti-cancer Immune Response in Colon Cancer

By: GlobenewsWire - 18 Aug 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 17 Aug 2020

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

WuXi AppTec Second-Quarter 2020 Results

By: PR Newswire Association LLC. - 13 Aug 2020

Related companies: WuXi AppTec, Inc. | WuXi AppTec Inc. | WuXi AppTec Advanced Therapies | WuXi AppTec

Samsung Biologics to add fourth plant with growing demands

INCHEON, South Korea, Aug. 10, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today held an online press conference to announce its plans to break ground for a fourth plant within this year. This is part of its long-term strategy to maximize its operational efficiency and scale up its... Read more ››

By: PR Newswire Association LLC. - 11 Aug 2020

Related companies: Samsung Biologics Co., Ltd.

Novo Nordisk's operating profit increased by 9% in Danish kroner and by 8% at constant exchange rates (CER) in the first six months of 2020

By: GlobenewsWire - 06 Aug 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 05 Aug 2020

Samsung Biologics launches S-CHOice cell line expression technology

INCHEON, South Korea, Aug. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today held an online ceremony to announce the launch of its proprietary cell line technology, S-CHOice.

By: PR Newswire Association LLC. - 05 Aug 2020

Related companies: Samsung Biologics Co., Ltd.

Macrogen Obtains Europe's CE-IVD Certificate for its COVID-19 Test Kit

- Export of test kit to entire Europe and numerous countries that recognize CE-IVD gains impetus

By: PR Newswire Association LLC. - 03 Aug 2020

Related companies: Macrogen Inc

Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine

By: GlobenewsWire - 31 Jul 2020

Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine

By: GlobenewsWire - 31 Jul 2020

Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial

By: GlobenewsWire - 30 Jul 2020

« 1 2 3 4 5 6 7

Looking for companies outside of Korea?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

January 2021
- NutrEvent
- AgeingFIT
February 2021
- Swiss Nordic Bio 2021

See Events »

Add an Event »

Latest company news

Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes
20 Jan 2021 (GlobenewsWire)

Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs
18 Jan 2021 (PR Newswire Association LLC.)

Novo Nordisk A/S – Share repurchase programme
18 Jan 2021 (GlobenewsWire)

News in the Life Sciences Industry

Qu Biologics is pleased to announce the appointment of Karn Manhas to Qu’s Board of Directors

Qu Biologics Initiates Phase 2 Study to Assess Activation of Anti-cancer Immune Response in Colon Cancer

Novo Nordisk A/S – Share repurchase programme

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

Samsung Biologics to add fourth plant with growing demands

Novo Nordisk's operating profit increased by 9% in Danish kroner and by 8% at constant exchange rates (CER) in the first six months of 2020

Novo Nordisk A/S – Share repurchase programme

Samsung Biologics launches S-CHOice cell line expression technology

Macrogen Obtains Europe's CE-IVD Certificate for its COVID-19 Test Kit

Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine

Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine

Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial

Online availability of Sanofi’s half-year financial report for 2020

Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation

Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine

Novo Nordisk A/S – Share repurchase programme

Looking for companies outside of Korea?

Partners

Upcoming Life Sciences Events

Latest company news